The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

Eli Lilly (NYSE:LLY) is taking the unusual step of asking people who took compounded versions of their drug tirzepatide, ...

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss ...

This partnership aims to extend The A-List Clinic’s reach, making it easier for people in the entertainment industry to learn ...

A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced ...

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body ...

Can weight loss medications trigger a thyroid crisis? In this case, rapid weight loss from tirzepatide led to ...

A new study explores the reasons why tirzepatide, the once-weekly injection used to treat obesity and type 2 diabetes, is ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. Tirzepatide is less expensive and may be more effective. However, the drug is still new, and more research is needed.

Across all studies and doses, females lost up to 24.6% of body weight from baseline whereas men lost a maximum of 18.1% of ...

Multiple studies have now shown that women drop more pounds than men when taking tirzepatide: 25 percent of their starting weight, on average, versus 18 percent for men. Women also report more ...